Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Inhibiting the PI3K/Akt pathway may help prevent radiation-induced liver injury.

High levels of phenyl glycidyl ether vapor caused hair loss in rats.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Connexin-26 gene mutations may increase cancer risk in KID syndrome patients.

Pesticides can cause reproductive and adrenal health issues.

Most U.S. keratinocyte carcinoma patients are older white males living in urban areas.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Lacking cyclin D3 reduces skin cancer growth without affecting normal skin cell growth.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

Overexpressing COX-2 in mice skin reduces skin tumor development.

Mild oxidative stress can prevent hair loss from chemotherapy.

These chemicals can be toxic and cause health issues like irritation, liver damage, and cancer.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Growth hormone may protect skin from radiation damage.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Overexpressing ATF3 in mice's epithelial cells may lead to oral cancer.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Workers exposed to certain jobs have higher levels of heavy metals in their hair.

Environmental and social factors greatly affect women's reproductive health.